Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ...
Revenues Tell The Story For Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) As Its Stock Soars 48%
Lesaffre Strengthens Its Research, Development & Innovation (RD&I) With the Acquisition of Altar, a Company Owned by Ginkgo Bioworks
Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $10
TD Cowen analyst Brendan Smith maintains $Ginkgo Bioworks(DNA.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 42.1% and a
Express News | Ginkgo Bioworks Holdings Inc : TD Cowen Raises Target Price to $10 From $3
TD Cowen Initiates Ginkgo Bioworks(DNA.US) With Buy Rating, Announces Target Price $10
TD Cowen analyst Brendan Smith initiates coverage on $Ginkgo Bioworks(DNA.US)$ with a buy rating, and sets the target price at $10.According to TipRanks data, the analyst has a success rate of 42.1%
Ginkgo Bioworks Holdings: A Buy Rating on Strategic AI Advancements and Market Expansion
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
Ginkgo Bioworks Executive Sells Over $1,900 in Stock
Is Ginkgo Bioworks Holdings, Inc. (DNA) A Good High Risk High Reward Growth Stock To Buy?
Ginkgo Bioworks Awarded $118M U.S. Government HHS Contract
NYSE to Commence Delisting Proceedings With Respect to the Warrants of Ginkgo Bioworks Holdings, Inc. (DNA.WS)
Ginkgo Regains Compliance With NYSE Minimum Bid Price Requirement
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference